title: In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptides.
authors.forename: Emilia
authors.initials: E
authors.lastname: Cercenado
authors.forename: Sonia
authors.initials: S
authors.lastname: Cercenado
authors.forename: Juan A
authors.initials: JA
authors.lastname: Gómez
authors.forename: Emilio
authors.initials: E
authors.lastname: Bouza
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016983:Enterococcus / Q000187:drug effects*; D008826:Microbial Sensitivity Tests; D008911:Minocycline / Q000031:analogs & derivatives* / Q000494:pharmacology*; D013210:Staphylococcus / Q000187:drug effects*; D000078304:Tigecycline; D014640:Vancomycin / Q000494:pharmacology; D020713:Vancomycin Resistance
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin; D000078304:Tigecycline; D008911:Minocycline